Characteristics of novel therapeutics and postmarket safety events - Reply

Nicholas S. Downing, Nilay D Shah, Joseph S. Ross

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)1067-1068
Number of pages2
JournalJAMA - Journal of the American Medical Association
Volume318
Issue number11
DOIs
StatePublished - Sep 19 2017

Fingerprint

Postmarketing Product Surveillance
United States Food and Drug Administration
Safety
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Characteristics of novel therapeutics and postmarket safety events - Reply. / Downing, Nicholas S.; Shah, Nilay D; Ross, Joseph S.

In: JAMA - Journal of the American Medical Association, Vol. 318, No. 11, 19.09.2017, p. 1067-1068.

Research output: Contribution to journalLetter

@article{2d897c13b610498ea5b31e86c24bc2b3,
title = "Characteristics of novel therapeutics and postmarket safety events - Reply",
author = "Downing, {Nicholas S.} and Shah, {Nilay D} and Ross, {Joseph S.}",
year = "2017",
month = "9",
day = "19",
doi = "10.1001/jama.2017.11517",
language = "English (US)",
volume = "318",
pages = "1067--1068",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - Characteristics of novel therapeutics and postmarket safety events - Reply

AU - Downing, Nicholas S.

AU - Shah, Nilay D

AU - Ross, Joseph S.

PY - 2017/9/19

Y1 - 2017/9/19

UR - http://www.scopus.com/inward/record.url?scp=85029652275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029652275&partnerID=8YFLogxK

U2 - 10.1001/jama.2017.11517

DO - 10.1001/jama.2017.11517

M3 - Letter

C2 - 28975302

AN - SCOPUS:85029652275

VL - 318

SP - 1067

EP - 1068

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 11

ER -